

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of integrated proviral latency (GO:0075713) | 5.00182978 |
| 2 | nuclear pore complex assembly (GO:0051292) | 4.74012639 |
| 3 | proteasome assembly (GO:0043248) | 4.04803021 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 3.96015636 |
| 5 | regulation of centriole replication (GO:0046599) | 3.92998451 |
| 6 | histone exchange (GO:0043486) | 3.82174692 |
| 7 | mitotic sister chromatid cohesion (GO:0007064) | 3.76673530 |
| 8 | metaphase plate congression (GO:0051310) | 3.76394452 |
| 9 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.72519541 |
| 10 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.70955530 |
| 11 | non-recombinational repair (GO:0000726) | 3.70955530 |
| 12 | DNA double-strand break processing (GO:0000729) | 3.69938314 |
| 13 | establishment of viral latency (GO:0019043) | 3.69568844 |
| 14 | mitotic sister chromatid segregation (GO:0000070) | 3.54954518 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.47352542 |
| 16 | sister chromatid segregation (GO:0000819) | 3.44659566 |
| 17 | DNA ligation (GO:0006266) | 3.44539274 |
| 18 | pore complex assembly (GO:0046931) | 3.41845042 |
| 19 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.40748072 |
| 20 | spindle checkpoint (GO:0031577) | 3.40723901 |
| 21 | cullin deneddylation (GO:0010388) | 3.36146517 |
| 22 | viral transcription (GO:0019083) | 3.35457524 |
| 23 | response to X-ray (GO:0010165) | 3.34624476 |
| 24 | translational termination (GO:0006415) | 3.33854809 |
| 25 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.30926097 |
| 26 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.29308143 |
| 27 | mitotic spindle checkpoint (GO:0071174) | 3.28986076 |
| 28 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.28783210 |
| 29 | tRNA aminoacylation for protein translation (GO:0006418) | 3.25957519 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24882374 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24882374 |
| 32 | amino acid activation (GO:0043038) | 3.24070691 |
| 33 | tRNA aminoacylation (GO:0043039) | 3.24070691 |
| 34 | cotranslational protein targeting to membrane (GO:0006613) | 3.22409621 |
| 35 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.22398437 |
| 36 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.22398437 |
| 37 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.22398437 |
| 38 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.22398437 |
| 39 | negative regulation of sister chromatid segregation (GO:0033046) | 3.22398437 |
| 40 | protein targeting to ER (GO:0045047) | 3.20771672 |
| 41 | negative regulation of chromosome segregation (GO:0051985) | 3.19799934 |
| 42 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19725404 |
| 43 | establishment of chromosome localization (GO:0051303) | 3.18614291 |
| 44 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.18312135 |
| 45 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.18312135 |
| 46 | DNA deamination (GO:0045006) | 3.18261057 |
| 47 | negative regulation of ligase activity (GO:0051352) | 3.15589512 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.15589512 |
| 49 | regulation of chromosome segregation (GO:0051983) | 3.15340063 |
| 50 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.14716977 |
| 51 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.14716977 |
| 52 | DNA strand elongation (GO:0022616) | 3.10887998 |
| 53 | postreplication repair (GO:0006301) | 3.09784337 |
| 54 | RNA-dependent DNA replication (GO:0006278) | 3.08086454 |
| 55 | protein localization to endoplasmic reticulum (GO:0070972) | 3.06293260 |
| 56 | protein deneddylation (GO:0000338) | 3.03576121 |
| 57 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.03414295 |
| 58 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.02912881 |
| 59 | regulation of sister chromatid segregation (GO:0033045) | 3.01971978 |
| 60 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.01971978 |
| 61 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.01971978 |
| 62 | mitotic spindle assembly checkpoint (GO:0007094) | 3.01096122 |
| 63 | ribosomal small subunit biogenesis (GO:0042274) | 3.00996640 |
| 64 | formation of translation preinitiation complex (GO:0001731) | 3.00815099 |
| 65 | DNA unwinding involved in DNA replication (GO:0006268) | 2.99513222 |
| 66 | spindle assembly checkpoint (GO:0071173) | 2.99332858 |
| 67 | replication fork processing (GO:0031297) | 2.97554911 |
| 68 | telomere maintenance via recombination (GO:0000722) | 2.96720619 |
| 69 | lactate metabolic process (GO:0006089) | 2.95709262 |
| 70 | L-serine metabolic process (GO:0006563) | 2.95637829 |
| 71 | nucleobase biosynthetic process (GO:0046112) | 2.94694699 |
| 72 | translational elongation (GO:0006414) | 2.94073109 |
| 73 | telomere maintenance via telomerase (GO:0007004) | 2.93466586 |
| 74 | regulation of centrosome cycle (GO:0046605) | 2.92734474 |
| 75 | positive regulation of chromosome segregation (GO:0051984) | 2.92042427 |
| 76 | maturation of SSU-rRNA (GO:0030490) | 2.91587879 |
| 77 | regulation of helicase activity (GO:0051095) | 2.90548959 |
| 78 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.90393132 |
| 79 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.89146925 |
| 80 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.89146925 |
| 81 | protein K6-linked ubiquitination (GO:0085020) | 2.88852502 |
| 82 | maturation of 5.8S rRNA (GO:0000460) | 2.87372720 |
| 83 | DNA damage response, detection of DNA damage (GO:0042769) | 2.87255864 |
| 84 | purine nucleobase biosynthetic process (GO:0009113) | 2.87062145 |
| 85 | translational initiation (GO:0006413) | 2.85561061 |
| 86 | spliceosomal snRNP assembly (GO:0000387) | 2.83792925 |
| 87 | rRNA modification (GO:0000154) | 2.83513797 |
| 88 | DNA replication initiation (GO:0006270) | 2.82903981 |
| 89 | histone mRNA metabolic process (GO:0008334) | 2.81165526 |
| 90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80105848 |
| 91 | CENP-A containing nucleosome assembly (GO:0034080) | 2.80035138 |
| 92 | mitotic recombination (GO:0006312) | 2.77692860 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.73245877 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.73091608 |
| 95 | chromatin remodeling at centromere (GO:0031055) | 2.69941916 |
| 96 | folic acid metabolic process (GO:0046655) | 2.67823970 |
| 97 | protein localization to kinetochore (GO:0034501) | 2.66113581 |
| 98 | viral life cycle (GO:0019058) | 2.65910865 |
| 99 | DNA replication checkpoint (GO:0000076) | 2.63602231 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62941650 |
| 101 | ribosomal large subunit biogenesis (GO:0042273) | 2.62016417 |
| 102 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.61298768 |
| 103 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.56355257 |
| 104 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.56355257 |
| 105 | mitotic metaphase plate congression (GO:0007080) | 2.56009253 |
| 106 | mitotic nuclear envelope disassembly (GO:0007077) | 2.55609094 |
| 107 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.53686308 |
| 108 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.53452448 |
| 109 | cellular protein complex disassembly (GO:0043624) | 2.52481587 |
| 110 | telomere maintenance via telomere lengthening (GO:0010833) | 2.52388584 |
| 111 | IMP biosynthetic process (GO:0006188) | 2.45343824 |
| 112 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.45139536 |
| 113 | B cell mediated immunity (GO:0019724) | 2.45061129 |
| 114 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.43993281 |
| 115 | DNA replication-independent nucleosome organization (GO:0034724) | 2.43993281 |
| 116 | kinetochore organization (GO:0051383) | 2.43373964 |
| 117 | tetrahydrofolate metabolic process (GO:0046653) | 2.41716517 |
| 118 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.41516363 |
| 119 | IMP metabolic process (GO:0046040) | 2.40033022 |
| 120 | ribosome assembly (GO:0042255) | 2.39790184 |
| 121 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.38902356 |
| 122 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.38358299 |
| 123 | membrane disassembly (GO:0030397) | 2.38121227 |
| 124 | nuclear envelope disassembly (GO:0051081) | 2.38121227 |
| 125 | protein localization to chromosome, centromeric region (GO:0071459) | 2.37710475 |
| 126 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.37697430 |
| 127 | natural killer cell mediated immunity (GO:0002228) | 2.37697430 |
| 128 | translation (GO:0006412) | 2.35172159 |
| 129 | regulation of spindle organization (GO:0090224) | 2.34115977 |
| 130 | * pentose-phosphate shunt (GO:0006098) | 2.31543927 |
| 131 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.30482591 |
| 132 | signal peptide processing (GO:0006465) | 2.29983765 |
| 133 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.29750683 |
| 134 | isotype switching (GO:0045190) | 2.29750683 |
| 135 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.29750683 |
| 136 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.28229818 |
| 137 | valine metabolic process (GO:0006573) | 2.27541152 |
| 138 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.26698458 |
| 139 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.25856950 |
| 140 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.23751608 |
| 141 | nuclear pore organization (GO:0006999) | 2.23137175 |
| 142 | glycine metabolic process (GO:0006544) | 2.21962812 |
| 143 | ribosome biogenesis (GO:0042254) | 2.21541065 |
| 144 | serine family amino acid biosynthetic process (GO:0009070) | 2.20347131 |
| 145 | rRNA processing (GO:0006364) | 2.19423306 |
| 146 | neutrophil activation involved in immune response (GO:0002283) | 2.19147303 |
| 147 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.19101282 |
| 148 | folic acid-containing compound metabolic process (GO:0006760) | 2.18800143 |
| 149 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.18716762 |
| 150 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.18716762 |
| 151 | regulation of protein heterodimerization activity (GO:0043497) | 2.18243591 |
| 152 | * NADPH regeneration (GO:0006740) | 2.18185786 |
| 153 | cell cycle G1/S phase transition (GO:0044843) | 2.16702690 |
| 154 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.16702690 |
| 155 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.15781495 |
| 156 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.15781495 |
| 157 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.15781495 |
| 158 | telomere organization (GO:0032200) | 2.15618528 |
| 159 | telomere maintenance (GO:0000723) | 2.14501090 |
| 160 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.14175935 |
| 161 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.13505734 |
| 162 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.13505734 |
| 163 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.12867516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.69357742 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.29816268 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.16332501 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.97213427 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.86326657 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.85482380 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72029889 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.71232050 |
| 9 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.61925325 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.43851990 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.41633106 |
| 12 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.35406240 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.32036962 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29180403 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.16920897 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15610786 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.13274828 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.11450995 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.07589040 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07008809 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04577767 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04534642 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.99737664 |
| 24 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.99187937 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98212037 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.97766527 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.93644911 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.90957037 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.86211233 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83672742 |
| 31 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82502347 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81428166 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79870749 |
| 34 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.77376046 |
| 35 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74481567 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74361971 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74355175 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74338598 |
| 39 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.72548806 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.71309943 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66609097 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65945953 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65663960 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65461934 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63627750 |
| 46 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.62669091 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62459098 |
| 48 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.61245035 |
| 49 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60656703 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60305974 |
| 51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57577484 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56359825 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55458995 |
| 54 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.55141630 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53678061 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53121738 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51391563 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46085233 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45809110 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.44843707 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44679171 |
| 62 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.43367495 |
| 63 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42581090 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42147928 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.37148818 |
| 66 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.36190085 |
| 67 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35371944 |
| 68 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34898764 |
| 69 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34237244 |
| 70 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33955083 |
| 71 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32371433 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.30715179 |
| 73 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30697627 |
| 74 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27843051 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27412623 |
| 76 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.27045231 |
| 77 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.26262018 |
| 78 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.26187495 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23486212 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22175412 |
| 81 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21865552 |
| 82 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21246574 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19690938 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19649367 |
| 85 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19161338 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19069675 |
| 87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18903192 |
| 88 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17508604 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17027008 |
| 90 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15557252 |
| 91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13847455 |
| 92 | MYB_26560356_Chip-Seq_TH2_Human | 1.13035219 |
| 93 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11699498 |
| 94 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11488593 |
| 95 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10983535 |
| 96 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10466951 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08597441 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07271680 |
| 99 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07100019 |
| 100 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06027765 |
| 101 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05953436 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05667937 |
| 103 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05567209 |
| 104 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05296722 |
| 105 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05286788 |
| 106 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03021449 |
| 107 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02487943 |
| 108 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02205152 |
| 109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00518349 |
| 110 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00412516 |
| 111 | MYC_22102868_ChIP-Seq_BL_Human | 1.00397540 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 0.99899155 |
| 113 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98526612 |
| 114 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.98315185 |
| 115 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97588930 |
| 116 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.95946308 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95629637 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95223791 |
| 119 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.95111844 |
| 120 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.94179418 |
| 121 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94126343 |
| 122 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91882728 |
| 123 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91647223 |
| 124 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90553863 |
| 125 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90165806 |
| 126 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89774838 |
| 127 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89760762 |
| 128 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89576403 |
| 129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86438265 |
| 130 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86057736 |
| 131 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84636480 |
| 132 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84116326 |
| 133 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.83050326 |
| 134 | P300_19829295_ChIP-Seq_ESCs_Human | 0.76641368 |
| 135 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.76029547 |
| 136 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.75017795 |
| 137 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73378197 |
| 138 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73281074 |
| 139 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.72877834 |
| 140 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.71380866 |
| 141 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.69950944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003941_abnormal_skin_development | 3.72049433 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.39193039 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.10195827 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 2.51603814 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.30771892 |
| 6 | MP0009785_altered_susceptibility_to | 2.28357940 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.26043722 |
| 8 | MP0003724_increased_susceptibility_to | 2.15128584 |
| 9 | MP0003436_decreased_susceptibility_to | 2.10497735 |
| 10 | MP0003186_abnormal_redox_activity | 2.05011377 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 1.97994938 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 1.94647539 |
| 13 | MP0003077_abnormal_cell_cycle | 1.93088294 |
| 14 | MP0002396_abnormal_hematopoietic_system | 1.92632673 |
| 15 | MP0008057_abnormal_DNA_replication | 1.90306201 |
| 16 | MP0000685_abnormal_immune_system | 1.87522723 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 1.87388927 |
| 18 | MP0003111_abnormal_nucleus_morphology | 1.86575383 |
| 19 | MP0005360_urolithiasis | 1.85541394 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.80225933 |
| 21 | MP0005671_abnormal_response_to | 1.76228156 |
| 22 | MP0002166_altered_tumor_susceptibility | 1.76140881 |
| 23 | MP0005025_abnormal_response_to | 1.66611619 |
| 24 | MP0002938_white_spotting | 1.63415262 |
| 25 | MP0001293_anophthalmia | 1.63094875 |
| 26 | MP0010307_abnormal_tumor_latency | 1.59594155 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.56990787 |
| 28 | MP0002006_tumorigenesis | 1.56681602 |
| 29 | MP0001697_abnormal_embryo_size | 1.56190216 |
| 30 | MP0001853_heart_inflammation | 1.53487599 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.52272931 |
| 32 | MP0001672_abnormal_embryogenesis/_devel | 1.51947671 |
| 33 | MP0005380_embryogenesis_phenotype | 1.51947671 |
| 34 | MP0002419_abnormal_innate_immunity | 1.50561712 |
| 35 | MP0003937_abnormal_limbs/digits/tail_de | 1.50342054 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.49148141 |
| 37 | MP0008007_abnormal_cellular_replicative | 1.46807098 |
| 38 | MP0001800_abnormal_humoral_immune | 1.46022285 |
| 39 | MP0000490_abnormal_crypts_of | 1.44962101 |
| 40 | MP0009840_abnormal_foam_cell | 1.43395845 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.42517222 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.41072301 |
| 43 | MP0002084_abnormal_developmental_patter | 1.40960557 |
| 44 | MP0006082_CNS_inflammation | 1.39884741 |
| 45 | MP0009672_abnormal_birth_weight | 1.36578674 |
| 46 | MP0000358_abnormal_cell_content/ | 1.35182620 |
| 47 | MP0002723_abnormal_immune_serum | 1.34623078 |
| 48 | MP0003984_embryonic_growth_retardation | 1.33919438 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.33207916 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.31254287 |
| 51 | MP0000858_altered_metastatic_potential | 1.30589001 |
| 52 | MP0001819_abnormal_immune_cell | 1.30114937 |
| 53 | MP0002085_abnormal_embryonic_tissue | 1.28698677 |
| 54 | MP0006054_spinal_hemorrhage | 1.28653416 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.28532073 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.28532073 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.28443287 |
| 58 | MP0002080_prenatal_lethality | 1.26893305 |
| 59 | MP0002398_abnormal_bone_marrow | 1.26472178 |
| 60 | MP0002090_abnormal_vision | 1.25290303 |
| 61 | MP0009379_abnormal_foot_pigmentation | 1.23874660 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.22971754 |
| 63 | MP0004947_skin_inflammation | 1.22734015 |
| 64 | MP0005365_abnormal_bile_salt | 1.20981214 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.20743604 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.20585358 |
| 67 | MP0006292_abnormal_olfactory_placode | 1.20317622 |
| 68 | MP0008058_abnormal_DNA_repair | 1.20220015 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.19471453 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.19219937 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19212896 |
| 72 | MP0002722_abnormal_immune_system | 1.18268915 |
| 73 | MP0002233_abnormal_nose_morphology | 1.17948973 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.16824980 |
| 75 | MP0003121_genomic_imprinting | 1.16802314 |
| 76 | MP0000716_abnormal_immune_system | 1.16654783 |
| 77 | MP0008469_abnormal_protein_level | 1.16377787 |
| 78 | MP0001790_abnormal_immune_system | 1.16157877 |
| 79 | MP0005387_immune_system_phenotype | 1.16157877 |
| 80 | MP0008932_abnormal_embryonic_tissue | 1.15967474 |
| 81 | MP0002697_abnormal_eye_size | 1.15255256 |
| 82 | MP0000647_abnormal_sebaceous_gland | 1.14636833 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 1.14567230 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.13501158 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 1.13130267 |
| 86 | MP0010155_abnormal_intestine_physiology | 1.12838586 |
| 87 | MP0002405_respiratory_system_inflammati | 1.12802836 |
| 88 | MP0000350_abnormal_cell_proliferation | 1.11070869 |
| 89 | MP0002429_abnormal_blood_cell | 1.09905914 |
| 90 | MP0005464_abnormal_platelet_physiology | 1.06883279 |
| 91 | MP0009764_decreased_sensitivity_to | 1.06551583 |
| 92 | MP0002086_abnormal_extraembryonic_tissu | 1.05802070 |
| 93 | MP0005058_abnormal_lysosome_morphology | 1.05629868 |
| 94 | MP0001730_embryonic_growth_arrest | 1.04220636 |
| 95 | MP0005023_abnormal_wound_healing | 1.03729898 |
| 96 | MP0001177_atelectasis | 1.03037829 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 1.02886904 |
| 98 | MP0000609_abnormal_liver_physiology | 1.02616374 |
| 99 | MP0003718_maternal_effect | 1.02557748 |
| 100 | MP0009763_increased_sensitivity_to | 1.01291932 |
| 101 | MP0001286_abnormal_eye_development | 1.00482790 |
| 102 | MP0001666_abnormal_nutrient_absorption | 0.99541998 |
| 103 | MP0009703_decreased_birth_body | 0.98987710 |
| 104 | MP0003123_paternal_imprinting | 0.98887617 |
| 105 | MP0004197_abnormal_fetal_growth/weight/ | 0.97796588 |
| 106 | MP0008438_abnormal_cutaneous_collagen | 0.97091274 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.95992181 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.95602883 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.95535760 |
| 110 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94231278 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.92388135 |
| 112 | MP0003448_altered_tumor_morphology | 0.91979750 |
| 113 | MP0002102_abnormal_ear_morphology | 0.90744307 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.86991361 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.86861232 |
| 116 | MP0000598_abnormal_liver_morphology | 0.85917028 |
| 117 | MP0000428_abnormal_craniofacial_morphol | 0.85825336 |
| 118 | MP0003950_abnormal_plasma_membrane | 0.85776442 |
| 119 | MP0009697_abnormal_copulation | 0.85744062 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.85196849 |
| 121 | MP0002111_abnormal_tail_morphology | 0.84888521 |
| 122 | MP0001243_abnormal_dermal_layer | 0.84653592 |
| 123 | MP0005395_other_phenotype | 0.84347908 |
| 124 | MP0004272_abnormal_basement_membrane | 0.83919342 |
| 125 | MP0000343_altered_response_to | 0.83915163 |
| 126 | MP0003755_abnormal_palate_morphology | 0.83622053 |
| 127 | MP0005332_abnormal_amino_acid | 0.83594980 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.82472802 |
| 129 | MP0001661_extended_life_span | 0.81792641 |
| 130 | MP0003786_premature_aging | 0.81537372 |
| 131 | MP0002796_impaired_skin_barrier | 0.81114434 |
| 132 | MP0002933_joint_inflammation | 0.80381164 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.80249756 |
| 134 | MP0000579_abnormal_nail_morphology | 0.79487151 |
| 135 | MP0000313_abnormal_cell_death | 0.78983209 |
| 136 | MP0001929_abnormal_gametogenesis | 0.78923796 |
| 137 | MP0002092_abnormal_eye_morphology | 0.78877484 |
| 138 | MP0002877_abnormal_melanocyte_morpholog | 0.78566356 |
| 139 | MP0005384_cellular_phenotype | 0.78209667 |
| 140 | MP0003705_abnormal_hypodermis_morpholog | 0.78024974 |
| 141 | MP0002160_abnormal_reproductive_system | 0.77882012 |
| 142 | MP0005408_hypopigmentation | 0.77535760 |
| 143 | MP0005248_abnormal_Harderian_gland | 0.77397843 |
| 144 | MP0005171_absent_coat_pigmentation | 0.76996059 |
| 145 | MP0003252_abnormal_bile_duct | 0.76920507 |
| 146 | MP0010329_abnormal_lipoprotein_level | 0.76793139 |
| 147 | MP0003566_abnormal_cell_adhesion | 0.76674011 |
| 148 | MP0002751_abnormal_autonomic_nervous | 0.76577580 |
| 149 | MP0002210_abnormal_sex_determination | 0.76183060 |
| 150 | MP0003935_abnormal_craniofacial_develop | 0.74927061 |
| 151 | MP0004381_abnormal_hair_follicle | 0.73934441 |
| 152 | MP0003385_abnormal_body_wall | 0.73060710 |
| 153 | MP0001529_abnormal_vocalization | 0.72287839 |
| 154 | MP0000427_abnormal_hair_cycle | 0.71678939 |
| 155 | MP0001727_abnormal_embryo_implantation | 0.71623619 |
| 156 | MP0001145_abnormal_male_reproductive | 0.69870219 |
| 157 | MP0005187_abnormal_penis_morphology | 0.68933909 |
| 158 | MP0005501_abnormal_skin_physiology | 0.68640819 |
| 159 | MP0002060_abnormal_skin_morphology | 0.68501709 |
| 160 | MP0001299_abnormal_eye_distance/ | 0.68488954 |
| 161 | MP0005220_abnormal_exocrine_pancreas | 0.67805229 |
| 162 | MP0000762_abnormal_tongue_morphology | 0.67381924 |
| 163 | MP0006036_abnormal_mitochondrial_physio | 0.67005709 |
| 164 | MP0003315_abnormal_perineum_morphology | 0.66983569 |
| 165 | MP0000653_abnormal_sex_gland | 0.66773200 |
| 166 | MP0005391_vision/eye_phenotype | 0.66153973 |
| 167 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66096452 |
| 168 | MP0004233_abnormal_muscle_weight | 0.65531130 |
| 169 | MP0000432_abnormal_head_morphology | 0.64503476 |
| 170 | MP0000627_abnormal_mammary_gland | 0.63363119 |
| 171 | MP0010030_abnormal_orbit_morphology | 0.62199330 |
| 172 | MP0004215_abnormal_myocardial_fiber | 0.62033376 |
| 173 | MP0001915_intracranial_hemorrhage | 0.60017951 |
| 174 | MP0009780_abnormal_chondrocyte_physiolo | 0.59890759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.22747289 |
| 2 | Chromsome breakage (HP:0040012) | 4.18508368 |
| 3 | Abnormality of chromosome stability (HP:0003220) | 3.79763868 |
| 4 | Abnormality of the labia minora (HP:0012880) | 3.52366908 |
| 5 | Meckel diverticulum (HP:0002245) | 3.49240550 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.25610519 |
| 7 | Abnormality of the ileum (HP:0001549) | 3.24958239 |
| 8 | Thrombocytosis (HP:0001894) | 3.24620586 |
| 9 | Abnormality of the preputium (HP:0100587) | 3.19502496 |
| 10 | Abnormality of glycolysis (HP:0004366) | 3.18973782 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 3.18674981 |
| 12 | Increased serum pyruvate (HP:0003542) | 3.17969868 |
| 13 | Reticulocytopenia (HP:0001896) | 3.12126880 |
| 14 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.03765914 |
| 15 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.99921701 |
| 16 | Birth length less than 3rd percentile (HP:0003561) | 2.99887007 |
| 17 | Embryonal renal neoplasm (HP:0011794) | 2.90039380 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88948105 |
| 19 | Eczematoid dermatitis (HP:0000976) | 2.87381110 |
| 20 | Abnormal lung lobation (HP:0002101) | 2.80863820 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 2.75429295 |
| 22 | Small intestinal stenosis (HP:0012848) | 2.74163023 |
| 23 | Duodenal stenosis (HP:0100867) | 2.74163023 |
| 24 | Rhabdomyosarcoma (HP:0002859) | 2.70044219 |
| 25 | Abnormality of the anterior horn cell (HP:0006802) | 2.70006775 |
| 26 | Degeneration of anterior horn cells (HP:0002398) | 2.70006775 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 2.65466303 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.64082145 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57193151 |
| 30 | Glioma (HP:0009733) | 2.56734896 |
| 31 | Multiple enchondromatosis (HP:0005701) | 2.45874537 |
| 32 | Acute encephalopathy (HP:0006846) | 2.45666725 |
| 33 | Abnormality of T cell number (HP:0011839) | 2.41886317 |
| 34 | Abnormality of the duodenum (HP:0002246) | 2.40905808 |
| 35 | Reduced antithrombin III activity (HP:0001976) | 2.40642651 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 2.38527453 |
| 37 | Ependymoma (HP:0002888) | 2.38472117 |
| 38 | Hypobetalipoproteinemia (HP:0003563) | 2.35812123 |
| 39 | Chronic otitis media (HP:0000389) | 2.35620339 |
| 40 | Medulloblastoma (HP:0002885) | 2.35156472 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.35077523 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.34711416 |
| 43 | Postnatal microcephaly (HP:0005484) | 2.33365064 |
| 44 | Megaloblastic anemia (HP:0001889) | 2.31543734 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.31520305 |
| 46 | Pallor (HP:0000980) | 2.29554673 |
| 47 | Microvesicular hepatic steatosis (HP:0001414) | 2.29480250 |
| 48 | Oral leukoplakia (HP:0002745) | 2.29445014 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.27862270 |
| 50 | Neoplasm of the adrenal gland (HP:0100631) | 2.27615750 |
| 51 | Microglossia (HP:0000171) | 2.27300563 |
| 52 | Increased nuchal translucency (HP:0010880) | 2.26834063 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 2.25216606 |
| 54 | Poor head control (HP:0002421) | 2.24035629 |
| 55 | T lymphocytopenia (HP:0005403) | 2.23178414 |
| 56 | Volvulus (HP:0002580) | 2.23161699 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.23065577 |
| 58 | Macrocytic anemia (HP:0001972) | 2.22364113 |
| 59 | Abnormality of T cells (HP:0002843) | 2.22224020 |
| 60 | Aplastic anemia (HP:0001915) | 2.22163902 |
| 61 | IgM deficiency (HP:0002850) | 2.21203529 |
| 62 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.21028587 |
| 63 | Agnosia (HP:0010524) | 2.17660927 |
| 64 | Bifid tongue (HP:0010297) | 2.16528842 |
| 65 | Neoplasm of the colon (HP:0100273) | 2.15755788 |
| 66 | Facial cleft (HP:0002006) | 2.15005861 |
| 67 | Abnormality of the carotid arteries (HP:0005344) | 2.12418135 |
| 68 | Recurrent viral infections (HP:0004429) | 2.11576788 |
| 69 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10012706 |
| 70 | Granulocytopenia (HP:0001913) | 2.09027146 |
| 71 | Myositis (HP:0100614) | 2.07866387 |
| 72 | Sloping forehead (HP:0000340) | 2.07232224 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.06881757 |
| 74 | Colon cancer (HP:0003003) | 2.06411367 |
| 75 | Abnormality of the astrocytes (HP:0100707) | 2.06356647 |
| 76 | Astrocytoma (HP:0009592) | 2.06356647 |
| 77 | Nausea (HP:0002018) | 2.05568926 |
| 78 | Intrahepatic cholestasis (HP:0001406) | 2.05539656 |
| 79 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05279073 |
| 80 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.05085679 |
| 81 | Abnormality of glycine metabolism (HP:0010895) | 2.05085679 |
| 82 | Combined immunodeficiency (HP:0005387) | 2.02888196 |
| 83 | Abnormal hemoglobin (HP:0011902) | 2.02332436 |
| 84 | Rough bone trabeculation (HP:0100670) | 2.02144649 |
| 85 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.01983561 |
| 86 | Hypoplasia of the thymus (HP:0000778) | 2.01937737 |
| 87 | IgG deficiency (HP:0004315) | 2.01258903 |
| 88 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.01076739 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.00629094 |
| 90 | Stenosis of the external auditory canal (HP:0000402) | 2.00374427 |
| 91 | B lymphocytopenia (HP:0010976) | 1.99895065 |
| 92 | Abnormality of B cell number (HP:0010975) | 1.99895065 |
| 93 | Hepatosplenomegaly (HP:0001433) | 1.99364285 |
| 94 | Recurrent bronchitis (HP:0002837) | 1.99296698 |
| 95 | Breast hypoplasia (HP:0003187) | 1.97632376 |
| 96 | Eosinophilia (HP:0001880) | 1.97539946 |
| 97 | Lipid accumulation in hepatocytes (HP:0006561) | 1.97356895 |
| 98 | Cerebral edema (HP:0002181) | 1.96826061 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.96434690 |
| 100 | Hypoglycemic coma (HP:0001325) | 1.96109913 |
| 101 | Hyperglycinuria (HP:0003108) | 1.95702007 |
| 102 | Spastic diplegia (HP:0001264) | 1.95679862 |
| 103 | Abnormal protein glycosylation (HP:0012346) | 1.94921457 |
| 104 | Abnormal glycosylation (HP:0012345) | 1.94921457 |
| 105 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94921457 |
| 106 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94921457 |
| 107 | Increased serum ferritin (HP:0003281) | 1.94804249 |
| 108 | Exertional dyspnea (HP:0002875) | 1.94318449 |
| 109 | Selective tooth agenesis (HP:0001592) | 1.93812187 |
| 110 | Myelodysplasia (HP:0002863) | 1.93644559 |
| 111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93180585 |
| 112 | Increased CSF lactate (HP:0002490) | 1.91781066 |
| 113 | Progressive macrocephaly (HP:0004481) | 1.90916391 |
| 114 | Ovarian neoplasm (HP:0100615) | 1.90231141 |
| 115 | Cortical dysplasia (HP:0002539) | 1.90072308 |
| 116 | Breast carcinoma (HP:0003002) | 1.89797473 |
| 117 | Stomatitis (HP:0010280) | 1.88862389 |
| 118 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.88137555 |
| 119 | Abnormal auditory evoked potentials (HP:0006958) | 1.88124209 |
| 120 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87552796 |
| 121 | Absent radius (HP:0003974) | 1.87279372 |
| 122 | Clubbing of toes (HP:0100760) | 1.85735959 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85412268 |
| 124 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85390743 |
| 125 | Xanthomatosis (HP:0000991) | 1.85218934 |
| 126 | Petechiae (HP:0000967) | 1.84880761 |
| 127 | Hyperglycinemia (HP:0002154) | 1.84411427 |
| 128 | 11 pairs of ribs (HP:0000878) | 1.83265411 |
| 129 | Secondary amenorrhea (HP:0000869) | 1.82620803 |
| 130 | Lymphoma (HP:0002665) | 1.81954198 |
| 131 | Uterine neoplasm (HP:0010784) | 1.81146082 |
| 132 | Symptomatic seizures (HP:0011145) | 1.81097638 |
| 133 | Embryonal neoplasm (HP:0002898) | 1.80845658 |
| 134 | Increased hepatocellular lipid droplets (HP:0006565) | 1.76877819 |
| 135 | Papillary thyroid carcinoma (HP:0002895) | 1.76158275 |
| 136 | Biliary tract neoplasm (HP:0100574) | 1.75089313 |
| 137 | Recurrent fungal infections (HP:0002841) | 1.74891806 |
| 138 | Abnormal cartilage morphology (HP:0002763) | 1.74388522 |
| 139 | Abnormality of methionine metabolism (HP:0010901) | 1.74127830 |
| 140 | Increased serum lactate (HP:0002151) | 1.73968092 |
| 141 | Leukocytosis (HP:0001974) | 1.73954552 |
| 142 | Hyperammonemia (HP:0001987) | 1.73954271 |
| 143 | Abnormality of alanine metabolism (HP:0010916) | 1.73724760 |
| 144 | Hyperalaninemia (HP:0003348) | 1.73724760 |
| 145 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73724760 |
| 146 | Increased muscle lipid content (HP:0009058) | 1.72669529 |
| 147 | Pustule (HP:0200039) | 1.72469916 |
| 148 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.70910964 |
| 149 | Urticaria (HP:0001025) | 1.70812305 |
| 150 | Absent forearm bone (HP:0003953) | 1.70703409 |
| 151 | Aplasia involving forearm bones (HP:0009822) | 1.70703409 |
| 152 | Pancytopenia (HP:0001876) | 1.70319664 |
| 153 | Horseshoe kidney (HP:0000085) | 1.70054060 |
| 154 | Triphalangeal thumb (HP:0001199) | 1.69882976 |
| 155 | Hepatic necrosis (HP:0002605) | 1.69559913 |
| 156 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.69381575 |
| 157 | Severe combined immunodeficiency (HP:0004430) | 1.69336880 |
| 158 | Choanal atresia (HP:0000453) | 1.69263137 |
| 159 | Neoplasm of the small intestine (HP:0100833) | 1.68288707 |
| 160 | Overlapping toe (HP:0001845) | 1.67448203 |
| 161 | Vasculitis (HP:0002633) | 1.67162043 |
| 162 | Microretrognathia (HP:0000308) | 1.67132291 |
| 163 | Abnormality of eosinophils (HP:0001879) | 1.66360214 |
| 164 | Trismus (HP:0000211) | 1.65449087 |
| 165 | Prolonged partial thromboplastin time (HP:0003645) | 1.65231629 |
| 166 | Amaurosis fugax (HP:0100576) | 1.65010654 |
| 167 | Delayed CNS myelination (HP:0002188) | 1.64613313 |
| 168 | Methylmalonic acidemia (HP:0002912) | 1.64031122 |
| 169 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.63996057 |
| 170 | Thyroid carcinoma (HP:0002890) | 1.62110001 |
| 171 | Neutropenia (HP:0001875) | 1.62090827 |
| 172 | Leukodystrophy (HP:0002415) | 1.61472986 |
| 173 | Generalized aminoaciduria (HP:0002909) | 1.60683482 |
| 174 | Gangrene (HP:0100758) | 1.60417744 |
| 175 | Increased IgM level (HP:0003496) | 1.60046855 |
| 176 | Ectopic kidney (HP:0000086) | 1.59417571 |
| 177 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.59032656 |
| 178 | Supernumerary spleens (HP:0009799) | 1.58234993 |
| 179 | Cafe-au-lait spot (HP:0000957) | 1.57661942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.77169720 |
| 2 | EIF2AK1 | 3.26631433 |
| 3 | WEE1 | 3.06095221 |
| 4 | BMPR1B | 2.70480576 |
| 5 | TESK2 | 2.59711297 |
| 6 | MKNK2 | 2.45261890 |
| 7 | PIM2 | 2.43007113 |
| 8 | NME2 | 2.42384453 |
| 9 | PBK | 2.41780920 |
| 10 | BCKDK | 2.32026595 |
| 11 | ACVR1B | 2.31172517 |
| 12 | EIF2AK3 | 2.26627806 |
| 13 | TRIM28 | 1.93531877 |
| 14 | IRAK4 | 1.91198638 |
| 15 | BRSK2 | 1.88025214 |
| 16 | MST4 | 1.86517980 |
| 17 | FLT3 | 1.81377712 |
| 18 | VRK2 | 1.79702153 |
| 19 | CDC7 | 1.78803211 |
| 20 | ERN1 | 1.78730276 |
| 21 | RPS6KA4 | 1.77198727 |
| 22 | TESK1 | 1.65459122 |
| 23 | STK16 | 1.62588065 |
| 24 | STK10 | 1.62209866 |
| 25 | SRPK1 | 1.56446503 |
| 26 | LRRK2 | 1.55180602 |
| 27 | TLK1 | 1.49952981 |
| 28 | TYK2 | 1.48977130 |
| 29 | STK38L | 1.46429234 |
| 30 | DYRK3 | 1.46110932 |
| 31 | MAP4K1 | 1.44271671 |
| 32 | TAF1 | 1.39001295 |
| 33 | BCR | 1.37454504 |
| 34 | ERBB3 | 1.36612001 |
| 35 | CDK8 | 1.36297582 |
| 36 | VRK1 | 1.34031523 |
| 37 | FRK | 1.32146307 |
| 38 | BLK | 1.30977517 |
| 39 | KDR | 1.29784823 |
| 40 | MAP3K12 | 1.28507516 |
| 41 | SCYL2 | 1.25420963 |
| 42 | BRSK1 | 1.23748990 |
| 43 | TEC | 1.21292664 |
| 44 | TBK1 | 1.19997540 |
| 45 | TGFBR1 | 1.18696668 |
| 46 | TNIK | 1.17611545 |
| 47 | PDK2 | 1.16403913 |
| 48 | RPS6KB2 | 1.16348187 |
| 49 | ZAP70 | 1.16069317 |
| 50 | TTK | 1.12839668 |
| 51 | MAP3K14 | 1.12690393 |
| 52 | MAPKAPK3 | 1.12046771 |
| 53 | NEK2 | 1.11815840 |
| 54 | JAK3 | 1.11042350 |
| 55 | BTK | 1.07559597 |
| 56 | AURKB | 1.07094655 |
| 57 | TXK | 1.06161983 |
| 58 | PLK2 | 1.04448884 |
| 59 | ERBB4 | 1.03337618 |
| 60 | IKBKE | 1.02427862 |
| 61 | MAP3K8 | 1.01144253 |
| 62 | PIM1 | 1.00414147 |
| 63 | LIMK1 | 0.97733906 |
| 64 | EIF2AK2 | 0.95711777 |
| 65 | PASK | 0.94541659 |
| 66 | KIT | 0.94350345 |
| 67 | CDK6 | 0.93720765 |
| 68 | WNK3 | 0.93186286 |
| 69 | STK3 | 0.92961104 |
| 70 | MAP4K2 | 0.91641200 |
| 71 | PLK1 | 0.89934629 |
| 72 | CSF1R | 0.89722838 |
| 73 | STK4 | 0.89624688 |
| 74 | CDK4 | 0.89563291 |
| 75 | ALK | 0.88735795 |
| 76 | EPHA2 | 0.88423773 |
| 77 | ATM | 0.87626073 |
| 78 | CSNK1G1 | 0.87534813 |
| 79 | ATR | 0.87095842 |
| 80 | NME1 | 0.83371543 |
| 81 | ARAF | 0.82913652 |
| 82 | CSK | 0.82084577 |
| 83 | IKBKB | 0.80697013 |
| 84 | PLK4 | 0.80291659 |
| 85 | NEK9 | 0.78713835 |
| 86 | IRAK3 | 0.77718177 |
| 87 | NEK1 | 0.77279130 |
| 88 | PNCK | 0.75842503 |
| 89 | NLK | 0.75343853 |
| 90 | CDK9 | 0.74274090 |
| 91 | FGFR1 | 0.73973981 |
| 92 | LATS1 | 0.73803402 |
| 93 | YES1 | 0.72305818 |
| 94 | CDK7 | 0.71405391 |
| 95 | BRAF | 0.69030781 |
| 96 | TSSK6 | 0.68076067 |
| 97 | CSNK1A1L | 0.67593835 |
| 98 | LYN | 0.66977200 |
| 99 | CSNK1G3 | 0.66938704 |
| 100 | STK24 | 0.64964001 |
| 101 | LCK | 0.62430039 |
| 102 | TAOK3 | 0.61393847 |
| 103 | AURKA | 0.60126581 |
| 104 | MST1R | 0.60008087 |
| 105 | PAK4 | 0.58992979 |
| 106 | STK39 | 0.58357260 |
| 107 | LMTK2 | 0.57300266 |
| 108 | CHEK2 | 0.56553297 |
| 109 | NEK6 | 0.56233894 |
| 110 | MAP3K3 | 0.54736145 |
| 111 | FGFR4 | 0.54320594 |
| 112 | LATS2 | 0.53556759 |
| 113 | CSNK1G2 | 0.53523345 |
| 114 | RPS6KA5 | 0.53469217 |
| 115 | MAP2K3 | 0.52367071 |
| 116 | PLK3 | 0.51546839 |
| 117 | ABL2 | 0.51304426 |
| 118 | MET | 0.51206249 |
| 119 | SYK | 0.50855269 |
| 120 | CSNK1E | 0.50037020 |
| 121 | MKNK1 | 0.49760434 |
| 122 | JAK1 | 0.49284951 |
| 123 | ZAK | 0.48053645 |
| 124 | MELK | 0.47222280 |
| 125 | TRPM7 | 0.47200366 |
| 126 | CSNK2A2 | 0.46568800 |
| 127 | MAP3K4 | 0.46466466 |
| 128 | CDK3 | 0.46068220 |
| 129 | DAPK1 | 0.45727406 |
| 130 | ITK | 0.45166201 |
| 131 | CSNK2A1 | 0.43031291 |
| 132 | NUAK1 | 0.41762523 |
| 133 | DYRK1B | 0.41315090 |
| 134 | OXSR1 | 0.41178505 |
| 135 | CHEK1 | 0.40177691 |
| 136 | FGFR3 | 0.40109181 |
| 137 | PKN2 | 0.39703007 |
| 138 | CDK1 | 0.38974716 |
| 139 | SIK1 | 0.38749973 |
| 140 | EEF2K | 0.37001632 |
| 141 | PRKCE | 0.36694708 |
| 142 | BRD4 | 0.36224500 |
| 143 | IRAK1 | 0.35195035 |
| 144 | PRKDC | 0.34616176 |
| 145 | CASK | 0.34368074 |
| 146 | FER | 0.33175712 |
| 147 | CDK2 | 0.30342500 |
| 148 | DYRK2 | 0.29957843 |
| 149 | FGFR2 | 0.28901187 |
| 150 | MAP2K7 | 0.23778180 |
| 151 | MAPKAPK5 | 0.20424783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.31737763 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.78794317 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.78683835 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.70468866 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.08054560 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.07303005 |
| 7 | Protein export_Homo sapiens_hsa03060 | 1.98946702 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 1.91375160 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.89213186 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 1.83029843 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79551327 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.75745190 |
| 13 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.75452906 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71783694 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.70221765 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.67842097 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.63969139 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.63248785 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57980134 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.54901710 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.45089740 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.43920135 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40194385 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.38037809 |
| 25 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.30027648 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27929692 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22426307 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.22278439 |
| 29 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.21200048 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20344626 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19616870 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16998919 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.13789239 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13319342 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11854862 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.08966573 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08161672 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06693696 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04746096 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03639754 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03356101 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01702691 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01508769 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01058989 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00657134 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.00651468 |
| 47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.99054620 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.98673575 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96916333 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96466725 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95393726 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94032047 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93630630 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93319573 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92834092 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91233916 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.88391998 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88348261 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86811605 |
| 60 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85405297 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.83377399 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83214912 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81926442 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81639579 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81140918 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78994069 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78546024 |
| 68 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77747817 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77516670 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76961957 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76373504 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76209368 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76173019 |
| 74 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75872682 |
| 75 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.75711514 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74892176 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74739740 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72940686 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72509619 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71622623 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71473118 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67599564 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67491217 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66554883 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63531097 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.62788121 |
| 87 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.62289452 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62144411 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62064330 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60400750 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.60250244 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.60007002 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59803591 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59325191 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59086315 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.56901406 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55766466 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.54585521 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52597476 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51942608 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51677799 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50892217 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49960134 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49780666 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49404116 |
| 106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49220317 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48677283 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47758569 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.46230032 |
| 110 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46045845 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45511481 |
| 112 | Adherens junction_Homo sapiens_hsa04520 | 0.45251750 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.43849239 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43521812 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43084311 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42721953 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42559145 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41698345 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40998130 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40644427 |
| 121 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40447168 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.40135413 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38291812 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36198114 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30082876 |
| 126 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29733121 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.27894820 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27666066 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26031364 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.23352053 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.21526497 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.20509517 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.19423343 |
| 134 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19338649 |
| 135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.18353521 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.15843126 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14882807 |

